The COVID-19 pandemic propelled mRNA technology into the spotlight, but what's next? This podcast explores the future of mRNA, focusing on the companies and trials to watch in 2025. We delve into how companies like Moderna, BioNTech, and Pfizer are moving beyond COVID-19 vaccines, applying mRNA technology to cancer, HIV, and other diseases. We'll discuss personalized cancer vaccines, like Moderna's mRNA-4157 and BioNTech's BNT122, as well as efforts to combat HIV. We also consider the potential of mRNA in flu and other respiratory diseases, and explore how some companies are looking at new delivery methods and self-amplifying mRNA. Join us as we examine whether mRNA will revolutionize medicine or face limitations due to cost and scalability.
